Skip to content
  • Home
  • Blog
  • Resources
  • Contact
  • About us
  • Position statement on open access
Open Pharma

Open Pharma

  • Home
  • Blog
  • Resources
  • Contact
  • About us
  • Position statement on open access

Category: Transparency

December 10, 2020December 10, 2020 Adeline Rosenberg Guest Posts, Open access, patients, Transparency

Publishing open access saves lives: accessibility

Why is accessibility such a crucial consideration of open access publishing, and how can we ensure content is sufficiently accessible?

Share this:

  • Tweet
November 26, 2020November 30, 2020 Adeline Rosenberg Guest Posts, Open access, Transparency

Publishing open access saves lives: equity and benefits

What are the benefits of open access publishing, and how can we improve equity in academic and medical communications?

Share this:

  • Tweet
July 19, 2019July 23, 2019 Chris Winchester Guest Posts, Transparency

Resolving conflicts of interest in medicine

At a workshop on managing conflicts of interest in medicine, Chris Winchester, CEO of Oxford PharmaGenesis and co-founder of Open Pharma, argued for openness.

Share this:

  • Tweet
July 10, 2019July 11, 2019 Paul Farrow Disclosure, Guest Posts, Transparency

Clinical trial transparency – time for pharma to go above and beyond?

On 11–12 June 2019, over 60 pharma stakeholders met in Amsterdam at the
8th Annual Publication and Clinical Trial Transparency Conference to discuss the evolving landscape of clinical trial transparency.

Share this:

  • Tweet
June 3, 2019June 3, 2019 Steph Macdonald Disclosure, Guest Posts, Open access, Peer review, Transparency

Clinical trial transparency – who’s watching?

On 15 May 2019, the Center for Biomedical Research Transparency (CBMRT) brought the stakeholders in academic publishing together to share their varying perspectives on research transparency and accessibility at the European Biomedical Transparency Summit (BMTS), in Paris.

Share this:

  • Tweet
September 14, 2018September 18, 2018 Amy Williams News, Open access, patients, Peer review, Preprints, Transparency

Weekly digest: what’s happening in open science?

Featuring pharma taking the lead on sharing clinical trial results, where preprints end up, and the identity of peer reviewers.

Share this:

  • Tweet
July 25, 2018August 15, 2018 Sarah Hadley Guest Posts, Transparency

Increasing transparency in biomedical research: CBMRT

In order to protect the quality of clinical research it is vital for all trials to be represented in scientific literature for the benefit of scientific progress and research efficiency, and, ultimately, to better inform care for our patients in a timely manner.

Share this:

  • Tweet
January 23, 2018June 11, 2018 Amy Williams Data, Open access, Transparency

Open Pharma at ISMPP Europe 2018

Here’s our summary of key points from selected presentations at the 2018 European meeting of ISMPP.

Share this:

  • Tweet
September 12, 2017August 15, 2018 Stuart Taylor Guest Posts, ORCID, Transparency

Cultivating ORCID at the Royal Society

Based on our experience, we believe that ORCID can make medical publishing faster and more transparent.

Share this:

  • Tweet
August 7, 2017August 15, 2018 Alison O'Connell Guest Posts, ORCID, Resources, Transparency

Tools supporting ethics and integrity in submission and review

With CRediT, ORCID and Publons integrated into Editorial Manager®, we aim for these transparency tools to be easy, standard steps in the publishing process

Share this:

  • Tweet

Posts navigation

Older posts

Subscribe

Join 367 other subscribers

Find content related to…

Follow us on Twitter

My Tweets

Search

Social

  • View _openpharma’s profile on Twitter